The composition-dependent presence of free (micellar) alkylphospholipid in liposomal formulations of octadecyl-1,1-dimethyl-piperidino-4-yl-phosphate affects its cytotoxic activity in vitro.
This study was performed to investigate the effect of cholesterol content, surface charge and sterical stabilization on the physico-chemical properties of liposomes prepared from the cancerostatic alkylphospholipid, octadecyl-1,1-dimethyl-piperidino-4-yl-phosphate (D21266), and their relationship to in vitro cytotoxicity. Stable incorporation of OPP into liposomes was found to be highly dependent on the cholesterol content. 31P-NMR spectroscopy as well as analysis of the lipid composition of OPP-containing liposome formulations revealed an increase in the amount of non-liposome-associated, micellar OPP as the cholesterol content decreased. The fraction of non-liposome-associated OPP constituted about 10% of total OPP when cholesterol was present in equimolar amounts (45.5/45.5 mol %) and increased to approximately 30% at a twofold excess of OPP over cholesterol (58.8/29.4 mol %). In monolayer incorporation studies it was shown that the existence of an increasing micellar pool of lipids leads to increased lipid transfer into the target monolayer. Liposome formulations containing more OPP than cholesterol were also found to display greater cytotoxicity. However, all liposome formulations were less cytotxic than pure (micellar) OPP. Cytotoxicity was not affected by the incorporation of N-methoxy-polyethyleneglycol2000-phosphoethanolamine, a lipid that is known to reduce liposome uptake into phagocytic cells. The results demonstrate that the increase in cell toxicity correlates with the increase in non-liposome-associated, micellar OPP, which can readily exchange into cellular membranes.
Zeisig
R
R
Max-Delbrück-Center for Molecular Medicine, 13092 Berlin-Buch, PF 74 02 38, Germany.
Müller
K
K
Maurer
N
N
Arndt
D
D
Fahr
A
A
D001943:Breast Neoplasms; D002455:Cell Division / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects*; D002626:Chemistry, Pharmaceutical; D002784:Cholesterol / Q000494:pharmacology; D004983:Ethanolamines / Q000494:pharmacology; D005260:Female; D005452:Fluoresceins / Q000032:analysis; D005562:Formazans / Q000032:analysis; D006801:Humans; D008081:Liposomes / Q000138:chemical synthesis / Q000737:chemistry* / Q000494:pharmacology*; D016859:Lipoxygenase Inhibitors; D009682:Magnetic Resonance Spectroscopy; D008823:Micelles; D010666:Phenylpropionates / Q000737:chemistry* / Q000494:pharmacology; D011092:Polyethylene Glycols / Q000494:pharmacology; D013778:Tetrazolium Salts / Q000032:analysis; D014407:Tumor Cells, Cultured
C402885:4-(2-oxapentadeca-4-yne)phenylpropanoic acid; D004983:Ethanolamines; D005452:Fluoresceins; D005562:Formazans; D008081:Liposomes; D016859:Lipoxygenase Inhibitors; D008823:Micelles; D010666:Phenylpropionates; D013778:Tetrazolium Salts; C079782:MTT formazan; D011092:Polyethylene Glycols; C005448:phosphorylethanolamine; D002784:Cholesterol; C007740:fluorexon